These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 33097690

  • 1. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J, Zelic M, Mahan A, Kothe M, Scholte AA, Fitzgerald M, Gisevius B, Haghikia A, Butovsky O, Ofengeim D.
    Cell Death Dis; 2020 Oct 23; 11(10):904. PubMed ID: 33097690
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML, Fleming SM, Budge KM, Boyle AM, Kim C, Alam G, Beier EE, Wu LJ, Richardson JR.
    FASEB J; 2020 Jan 23; 34(1):1679-1694. PubMed ID: 31914683
    [Abstract] [Full Text] [Related]

  • 3. Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery.
    Nissen JC, Thompson KK, West BL, Tsirka SE.
    Exp Neurol; 2018 Sep 23; 307():24-36. PubMed ID: 29803827
    [Abstract] [Full Text] [Related]

  • 4. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ, Ritzel RM, Barrett JP, Doran SJ, Jiao Y, Leach JB, Szeto GL, Wu J, Stoica BA, Faden AI, Loane DJ.
    J Neurosci; 2020 Apr 01; 40(14):2960-2974. PubMed ID: 32094203
    [Abstract] [Full Text] [Related]

  • 5. Increased Microglial CSF1R Expression in the SIV/Macaque Model of HIV CNS Disease.
    Knight AC, Brill SA, Queen SE, Tarwater PM, Mankowski JL.
    J Neuropathol Exp Neurol; 2018 Mar 01; 77(3):199-206. PubMed ID: 29319809
    [Abstract] [Full Text] [Related]

  • 6. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O, Laflamme N, Piret J, Venable MC, Carbonneau J, Zarrouk K, Rivest S, Boivin G.
    J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32938766
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J, Simon E, Martin-Estebane M, Pipi E, Barkwill LM, Gonzalez-Rivera I, Buchanan F, Prescott AR, Faust D, Fox S, Brownlees J, Taylor D, Perry VH, Nuthall H, Atkinson PJ, Karran E, Routledge C, Gomez-Nicola D.
    Front Immunol; 2020 Nov 09; 11():579000. PubMed ID: 33162994
    [Abstract] [Full Text] [Related]

  • 8. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
    Tahmasebi F, Pasbakhsh P, Mortezaee K, Madadi S, Barati S, Kashani IR.
    J Cell Biochem; 2019 Jun 09; 120(6):10576-10586. PubMed ID: 30628737
    [Abstract] [Full Text] [Related]

  • 9. Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCε pathway in a rat model of neonatal HIE.
    Hu X, Li S, Doycheva DM, Huang L, Lenahan C, Liu R, Huang J, Xie S, Tang J, Zuo G, Zhang JH.
    J Neuroinflammation; 2020 Jun 10; 17(1):182. PubMed ID: 32522286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression and activation of colony-stimulating factor 1 receptor in the SIV/macaque model of HIV infection and neuroHIV.
    Irons DL, Meinhardt T, Allers C, Kuroda MJ, Kim WK.
    Brain Pathol; 2019 Nov 10; 29(6):826-836. PubMed ID: 31033097
    [Abstract] [Full Text] [Related]

  • 13. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, Navarro X, Gomez-Nicola D, López-Vales R.
    Sci Rep; 2016 May 13; 6():25663. PubMed ID: 27174644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D.
    Brain; 2016 Mar 13; 139(Pt 3):891-907. PubMed ID: 26747862
    [Abstract] [Full Text] [Related]

  • 17. Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis model.
    Ganz T, Fainstein N, Theotokis P, Elgavish S, Vardi-Yaakov O, Lachish M, Sofer L, Zveik O, Grigoriadis N, Ben-Hur T.
    Brain Behav Immun; 2024 Nov 13; 122():497-509. PubMed ID: 39179123
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss.
    Gushchina S, Pryce G, Yip PK, Wu D, Pallier P, Giovannoni G, Baker D, Bo X.
    Glia; 2018 Oct 13; 66(10):2108-2125. PubMed ID: 30144320
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.